Gollob Jared sold KYMR
October 13, 2025 · Form 4 insider transaction
Gollob Jared sold 3,114 shares of Kymera Therapeutics, Inc. at $60.00 per share, a transaction worth $186.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,114
Price
$60.00
Total value
$186.8K
InsiderGollob Jared
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 13, 2025
Filing dateOctober 14, 2025
Shares owned after118,359
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2025 adopted by the reporting person.